[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Databases::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: ::
Back to the articles list Back to browse issues page
9
Roghieh Golsha1 , Hesamaddin Shirzad-Aski2 , Erfan Rezaieshirazi3 , Helia Borujerdi Karimi4 , Samira Eshghinia *5
1- Professor of Infectious Diseases Research Center, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran.
2- Assistant Professor of Infectious Diseases Research Center, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran.
3- Genral Physician, Infectious Diseases Research Center, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran.
4- Medical Student, Infectious Diseases Research Center, Jorjani Clinical sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran.
5- Associate Professor of Metabolic Disorders Research Center, Biomedical Research Institute, Golestan University of Medical Sciences, Gorgan, Iran. Ischemic Disorders Research Center, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran. , dreshghinia@yahoo.com
Abstract:   (4402 Views)
This article has no abstract.
Keywords: Infections [MeSH], Bacteria [MeSH], Microbial Sensitivity Tests [MeSH], Sepsis [MeSH], Urinary Tract Infections [MeSH]
Article ID: Vol28-19
Full-Text [PDF 839 kb]   (864 Downloads)    
Type of Study: Original Articles | Subject: Infectious Medicine
References
1. GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024 Sep;404(10459):1199-226. https://doi.org/10.1016/s0140-6736(24)01867-1. [DOI] [PubMed]
2. Nauclér P, Huttner A, van Werkhoven CH, Singer M, Tattevin P, Einav S, et al. Impact of time to antibiotic therapy on clinical outcome in patients with bacterial infections in the emergency department: implications for antimicrobial stewardship. Clin Microbiol Infect. 2021 Feb;27(2):175-81. https://doi.org/10.1016/j.cmi.2020.02.032. [DOI] [PubMed]
3. Hung YP, Lee CC, Ko WC. Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis. Front Med (Lausanne). 2022 May;9:869822. https://doi.org/10.3389/fmed.2022.869822. [DOI] [PubMed]
4. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014 Dec;5(6):229-41. https://doi.org/10.1177/2042098614554919. [DOI] [PubMed]
5. Pierce VM, Bhowmick T, Simner PJ. Guiding antimicrobial stewardship through thoughtful antimicrobial susceptibility testing and reporting strategies: an updated approach in 2023. J Clin Microbiol. 2023 Nov;61(11):e0007422. https://doi.org/10.1128/jcm.00074-22. [DOI] [PubMed]
6. Kullberg RFJ, Haak BW, Chanderraj R, Prescott HC, Dickson RP, Wiersinga WJ. Empirical antibiotic therapy for sepsis: save the anaerobic microbiota. Lancet Respir Med. 2025 Jan;13(1):92-100. https://doi.org/10.1016/s2213-2600(24)00257-1. [DOI] [PubMed]
7. Gohil SK, Septimus E, Kleinman K, Varma N, Sands KE, Avery TR, et al. Improving Empiric Antibiotic Selection for Patients Hospitalized With Skin and Soft Tissue Infection: The INSPIRE 3 Skin and Soft Tissue Randomized Clinical Trial. JAMA Intern Med. 2025 Jun;185(6):680-91. https://doi.org/10.1001/jamainternmed.2025.0887. [DOI] [PubMed]
8. Prescott HC, Iwashyna TJ. Improving Sepsis Treatment by Embracing Diagnostic Uncertainty. Ann Am Thorac Soc. 2019 Apr;16(4):426-29. https://doi.org/10.1513/annalsats.201809-646ps. [DOI] [PubMed]
9. Cressman AM, MacFadden DR, Verma AA, Razak F, Daneman N. Empiric Antibiotic Treatment Thresholds for Serious Bacterial Infections: A Scenario-based Survey Study. Clin Infect Dis. 2019 Aug;69(6):930-37. https://doi.org/10.1093/cid/ciy1031. [DOI] [PubMed]
10. Kollef MH, Burnham JP. Antibiotic Thresholds for Sepsis and Septic Shock. Clin Infect Dis. 2019 Aug;69(6):938-40. https://doi.org/10.1093/cid/ciy1035. [DOI] [PubMed]
11. Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E. Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs. Antimicrob Agents Chemother. 2016 Jul;60(8):4840-52. https://doi.org/10.1128/aac.00825-16. [DOI] [PubMed]
12. Nelson GE, Narayanan N, Onguti S, Stanley K, Newland JG, Doernberg SB. Principles and Practice of Antimicrobial Stewardship Program Resource Allocation. Infect Dis Clin North Am. 2023 Dec;37(4):683-714. https://doi.org/10.1016/j.idc.2023.07.002. [DOI] [PubMed]
13. Tacconelli E, Cataldo MA, Mutters NT, Carrara E, Bartoloni A, Raglio A, et al. Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections. Int J Antimicrob Agents. 2019 Jul;54(1):49-54. https://doi.org/10.1016/j.ijantimicag.2019.04.007. [DOI] [PubMed]
14. Bazvand S, Jafari NJ, Panahi Y, Rezaei MA, Goodarzi H. Investigating the pattern of antibiotic prescription in the emergency department of Baqiyatallah hospital. International Journal of Travel Medicine & Global Health. 2025;13(2):70. [Link]
15. Gürtler N, Erba A, Giehl C, Tschudin-Sutter S, Bassetti S, Osthoff M. Appropriateness of antimicrobial prescribing in a Swiss tertiary care hospital: a repeated point prevalence survey. Swiss Med Wkly. 2019 Oct;149:w20135. https://doi.org/10.4414/smw.2019.20135. [DOI] [PubMed]
16. Luo Y, Guo Z, Li Y, Ouyang H, Huang S, Chen Y, et al. Appropriateness of Empirical Antibiotic Therapy in Hospitalized Patients with Bacterial Infection: A Retrospective Cohort Study. Infect Drug Resist. 2023 Jul;16:4555-68. https://doi.org/10.2147/idr.s402172. [DOI] [PubMed]
17. Fromer DL, Luck ME, Cheng WY, Mahendran M, da Costa WL, Pinaire M, et al. Risk Factors for Empiric Treatment Failure in US Female Outpatients with Uncomplicated Urinary Tract Infection: an Observational Study. J Gen Intern Med. 2025 Mar;40(4):862-70. https://doi.org/10.1007/s11606-024-09029-6. [DOI] [PubMed]
18. Tićac M, Grubić Kezele T, Bubonja Šonje M. Impact of Appropriate Empirical Antibiotic Treatment on the Clinical Response of Septic Patients in Intensive Care Unit: A Single-Center Observational Study. Antibiotics (Basel). 2024 Jun;13(6):569. https://doi.org/10.3390/antibiotics13060569. [DOI] [PubMed]
19. Rojas A, Palacios-Baena ZR, López-Cortés LE, Rodríguez-Baño J. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis. Clin Microbiol Infect. 2019 Aug;25(8):964-70. https://doi.org/10.1016/j.cmi.2019.04.005. [DOI] [PubMed]
Send email to the article author


XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Back to the articles list Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.08 seconds with 35 queries by YEKTAWEB 4774
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)